2014
DOI: 10.1134/s0026893314060077
|View full text |Cite
|
Sign up to set email alerts
|

G-quadruplex ligands: Mechanisms of anticancer action and target binding

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(16 citation statements)
references
References 106 publications
0
14
0
2
Order By: Relevance
“…[17][18][19][20][21][22] Due to their regulatory function in pathological processes, G-quadruplexes have been identified as interesting drug targets in anticancer research. [23][24][25] Many small molecules [26] and metal complexes, [27] most of them possessing flat psurfaces and positive charges, were found to bind and stabilize the folded secondary structure, thereby acting as potential anticancer drugs. [28] One well-known G-quadruplex binder is the natural product telomestatin, [29,30] which is a potent telomerase inhibitor due to its strong interaction with unimolecular G-quadruplexes found in the human telomeric sequence.…”
Section: Introductionmentioning
confidence: 99%
“…[17][18][19][20][21][22] Due to their regulatory function in pathological processes, G-quadruplexes have been identified as interesting drug targets in anticancer research. [23][24][25] Many small molecules [26] and metal complexes, [27] most of them possessing flat psurfaces and positive charges, were found to bind and stabilize the folded secondary structure, thereby acting as potential anticancer drugs. [28] One well-known G-quadruplex binder is the natural product telomestatin, [29,30] which is a potent telomerase inhibitor due to its strong interaction with unimolecular G-quadruplexes found in the human telomeric sequence.…”
Section: Introductionmentioning
confidence: 99%
“…Chemical structures and associated activity data for approximately one thousand ligands are currently curated in the online G4 ligand database, and new chemotypes are frequently reported . Progress towards the goal of G4‐targeted therapy is frequently documented and it is not our intention to cover general G4 ligand design principles in this review, since they are covered comprehensively elsewhere , , . However, over the course of our endeavors in G4 ligand chemistry we have become more deeply interested in the potential of ligands to do more than simply bind G4 with the aim of enhancing their stability or extending their lifetime in vivo.…”
Section: Introductionmentioning
confidence: 99%
“…Amongst the myriad of small molecule G4-binding ligands that have been synthesized one can find examples of ligands binding grooves, loop sequences, and tetrad faces of G4s. In some cases, binding of these ligands has been shown to stabilize, destabilize, and even alter the conformation of the G4 [ 5 7 ]. It would not be unreasonable to hypothesize that as our knowledge of protein-G4 interactions increases we will have examples of proteins that do the same.…”
Section: Introductionmentioning
confidence: 99%